The first human experience in a tertiary center in Italy with the V-LAP, a wireless left atrial pressure monitoring system for patients with heart failure with reduced ejection fraction.
The case 68-year-old male Body height: 182 cm Body weight: 80 kg Sex: male Total cholesterol: 150 mg/dl Glycated haemoglobin: 8.2% Duration of T2DM: 15 years Blood pressure: 139/95 mmHg Medication ...
The risk of death is highest in the first 6 months following myocardial infarction (MI).1,2 However, current ESC Guidelines recommend a delay of at least 6 weeks after MI before considering ...
Association between beta-blocker use and mortality/morbidity in elderly patients with heart failure with reduced ejection fraction: a prospective propensity score-matched cohort study
The impact of regulatory T lymphocytes on long-term survival in patients with ischemic heart failure with reduced ejection fraction
Plasma proteomic profile predicts survival in heart failure with reduced ejection fraction
Mortality and prognostic factors in dilated cardiomyopathy versus ischaemic heart disease in patients with heart failure with reduced ejection fraction - a Swedish population-based study
Analysis of novel cardiac markers sST2 and IL-33 in chronic heart failure with reduced ejection fraction
Non-terminating ventricular arrhythmias during exercise testing reflect poorer prognosis and advanced disease severity in heart failure regardless of ejection fraction
Improvement in ejection fraction predicts heart failure after catheter ablation for atrial fibrillation in patients with left ventricular systolic dysfunction : from the KPAF registry